Int. Society for the Study of Xenobiotics: ISSX Africa: Transforming Science, Connecting Worlds

African populations represent approximately 17% of the world’s
population, yet remain significantly underrepresented in drug
metabolism and pharmacokinetics (DMPK) research, limiting our
ability to develop safe, effective medicines. International Society for the Study of Xenobiotics saw an opportunity to turn this challenge into action through three goals: bringresearchers together, build regional DMPK expertise, and create a foundation for sustained collaboration.

First, ISSX brought together 80 researchers and students from across
Africa for an intensive workshop focused on pharmacogenomics,
pharmacokinetics, and drug-drug interactions. The workshop strengthened knowledge, built connections, and sparked
collaborations that continue to influence drug development across
Africa.

Second, ISSX partnered with regional leaders to establish the ISSX
Africa affiliate, officially launched in March 2025. The affiliate
provides an ongoing platform for regional programming and
collaboration, supported by ISSX as it transitions toward independent
operations and long-term sustainability.

Finally, ISSX continues to connect African researchers with the
broader ISSX community, expanding access to expertise and ensuring
African data, perspectives, and scientists have a stronger voice in
global drug development.

The result is a scalable model for leveraging association networks
and credibility to build capacity, broaden inclusion, and bring new
perspectives to global science.